KR101844369B1 - Plum tea composition for enhancing concentration and psychological stability and uses thereof - Google Patents
Plum tea composition for enhancing concentration and psychological stability and uses thereof Download PDFInfo
- Publication number
- KR101844369B1 KR101844369B1 KR1020170108816A KR20170108816A KR101844369B1 KR 101844369 B1 KR101844369 B1 KR 101844369B1 KR 1020170108816 A KR1020170108816 A KR 1020170108816A KR 20170108816 A KR20170108816 A KR 20170108816A KR 101844369 B1 KR101844369 B1 KR 101844369B1
- Authority
- KR
- South Korea
- Prior art keywords
- plum
- power spectrum
- alpha
- ratio
- absolute
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 241001122767 Theaceae Species 0.000 title claims abstract description 30
- 230000002708 enhancing effect Effects 0.000 title claims description 9
- 238000001228 spectrum Methods 0.000 claims abstract description 45
- 102100021709 Rho guanine nucleotide exchange factor 4 Human genes 0.000 claims abstract description 13
- 101710128386 Rho guanine nucleotide exchange factor 4 Proteins 0.000 claims abstract description 13
- 210000001652 frontal lobe Anatomy 0.000 claims abstract description 8
- 235000013376 functional food Nutrition 0.000 claims abstract description 8
- 230000036541 health Effects 0.000 claims abstract description 8
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 36
- 229930091371 Fructose Natural products 0.000 claims description 10
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 10
- 239000005715 Fructose Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 9
- 210000003478 temporal lobe Anatomy 0.000 claims description 6
- 230000003247 decreasing effect Effects 0.000 claims description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 239000011707 mineral Substances 0.000 claims description 3
- 235000010755 mineral Nutrition 0.000 claims description 3
- 150000007524 organic acids Chemical class 0.000 claims description 3
- 229920002230 Pectic acid Polymers 0.000 claims description 2
- 239000000783 alginic acid Substances 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 229960001126 alginic acid Drugs 0.000 claims description 2
- 150000004781 alginic acids Chemical class 0.000 claims description 2
- 235000014171 carbonated beverage Nutrition 0.000 claims description 2
- 239000003086 colorant Substances 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- 239000003002 pH adjusting agent Substances 0.000 claims description 2
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 claims description 2
- 239000010318 polygalacturonic acid Substances 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 239000000084 colloidal system Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 235000005985 organic acids Nutrition 0.000 claims 1
- 230000001681 protective effect Effects 0.000 claims 1
- 239000002562 thickening agent Substances 0.000 claims 1
- 230000007423 decrease Effects 0.000 abstract description 9
- 230000003595 spectral effect Effects 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 8
- 230000003340 mental effect Effects 0.000 abstract description 7
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 230000002360 prefrontal effect Effects 0.000 abstract description 5
- 210000004556 brain Anatomy 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 235000021110 pickles Nutrition 0.000 description 8
- 229920000715 Mucilage Polymers 0.000 description 7
- 239000000853 adhesive Substances 0.000 description 7
- 235000021018 plums Nutrition 0.000 description 7
- 230000000087 stabilizing effect Effects 0.000 description 7
- 230000008859 change Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 238000013507 mapping Methods 0.000 description 5
- 230000015654 memory Effects 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 210000002475 olfactory pathway Anatomy 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 230000007177 brain activity Effects 0.000 description 3
- 210000001320 hippocampus Anatomy 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 210000000956 olfactory bulb Anatomy 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- 240000001980 Cucurbita pepo Species 0.000 description 2
- 235000009852 Cucurbita pepo Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229950001002 cianidanol Drugs 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 238000002599 functional magnetic resonance imaging Methods 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 235000021109 kimchi Nutrition 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 210000000196 olfactory nerve Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 210000000225 synapse Anatomy 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 206010016352 Feeling of relaxation Diseases 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 102000012547 Olfactory receptors Human genes 0.000 description 1
- 108050002069 Olfactory receptors Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 235000020831 absolute fast Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000974 brodmann area Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 235000021403 cultural food Nutrition 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000000624 ear auricle Anatomy 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 210000005153 frontal cortex Anatomy 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 210000003715 limbic system Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 238000002600 positron emission tomography Methods 0.000 description 1
- 210000002442 prefrontal cortex Anatomy 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000008786 sensory perception of smell Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229940035637 spectrum-4 Drugs 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/22—Drying or concentrating tea extract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/18—Extraction of water soluble tea constituents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/31—Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
Description
본 발명은 집중력 강화 및 심리적 안정용 매실차 조성물, 상기 매실차 조성물을 포함하는 집중력 강화 및 심리적 안정용 건강기능식품, 집중력 강화 및 심리적 안정 효과를 지니는 매실차의 제조방법 및 상기 방법으로 제조된 매실차에 관한 것이다.
The present invention relates to a method for preparing a plum tea composition for enhancing concentration and psychological stability, a health functional food for enhancing concentration and psychological stability comprising the plum tea composition, a method for producing a plum tea having concentration and psychological stabilizing effect, .
인간이 냄새를 맡고 인지하는 후각감지는 여섯 단계로 구성된 후각생성 및 전달과정으로 이해되고 있다. 제1단계에서는 공기 중의 냄새분자가 콧구멍으로 냄새분자의 들어오고, 제2단계에서는 비강내 후각수용체 세포가 냄새분자를 인지하고 신경세포섬유를 통해 후각망울로 자료를 전송하게 된다. 이때 후각망울로 전달되는 자료는 전기적인 자극이다. 제3단계에서는 후각망울에서 후각로를 따라 후각피질로 전기적인 신호가 전송되고, 제4단계에서는 후각망을에서 온 신호가 안와전두엽피질과 편도로 전달되며, 제5단계에서는 후각피질에서 전달된 신호를 안와전두엽피질에서 후각인식 과정을 수행하며, 제6단계에서는 위험상황과 관련이 있는 냄새의 경우 신호를 받아 편도에서 두려운 마음이 들게 한다.The sense of smell that the human perceives as smell is understood as the process of olfactory generation and transmission consisting of six steps. In the first stage, the odor molecules in the air enter the nostrils, and in the second stage, the nasal olfactory receptors recognize the odor molecules and transmit the data to the olfactory bulb through the nerve cell fibers. The data transmitted to the olfactory bulb are electrical stimuli. In the third step, electrical signals are transmitted from the olfactory bulb to the olfactory cortex along the olfactory cortex. In the fourth step, the signal from the olfactory nerve is transmitted to the orbital frontal cortex and the tonsil. In the fifth step, Signals are processed in the oropharyngeal cortex in the olfactory cognition process. In the sixth step, the smell related to the dangerous situation is signaled to cause fear in one direction.
위에서 언급된 후각 경로는 조롱박피질(piriform cortex)까지는 잘 알려져 있으나 신피질로의 투사 및 그들의 기능적 조직화에 대해서는 명확하게 구명된 바가 없다. 양성자방출단층촬영(positron emission tomography, PET)과 기능적 자기공명영상술(functional magnetic resonance imaging, fMRI)을 이용한 신경영상술의 연구결과들은 냄새를 맡기 위한 킁킁거림(sniffing)은 일차적으로 조롱박피질과 안와전두이랑의 내측 및 후반부에 의해 활성화가 유도되며, 냄새를 감지하는 것(smelling)은 안와전두이랑의 외측 및 전반부의 활성화에 의해 기안되는 것으로 알려져 있으며, 조롱박피질, 안와전두피질, 편도 및 해마지역과 많은 연결이 있는 것으로 알려져 있다(정기영, 김재문, 이일근, 김지현, 주은연, 홍승봉, 변홍식, 이주형. 2004. 방향성 후각자극에 의한 대뇌피질의 활성: Low Resolution Electromagnetic Tomography(LORETA)를 이용한 비모수 통계 지도. 대한신경과학회진 22(4):334-339.).The olfactory pathways mentioned above are well known up to the piriform cortex, but the projection into the cortex and their functional organization have not been clearly elucidated. The results of neurophysiologic studies using positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) showed that sniffing for smell was primarily associated with gourd cortex and orbital frontal The smearing is known to be caused by the activation of the outer and the anterior parts of the orbital frontal gyre, and the gourd cortex, oropharyngeal cortex, 2004). Cerebral Cortical Activity by Directional Olfactory Stimulation: A Nonparametric Statistical Map Using Low Resolution Electromagnetic Tomography (LORETA). (Korean J Thorac Cardiovasc Surg 1999; Korean Neuroscience Society 22 (4): 334-339.).
대뇌피질에서 후각과 관련이 있는 브로드만 영역은 중간관자엽의 28번과 34번이며, 후각적 경험은 기억으로 저장되는데 특히 냄새는 감각 중에서 가장 강력한 관계가 있으며 후각경험은 일년~수십년간 지속되기도 한다. 후각부위는 변연계에서 감정을 조절하는 부위와 연관이 있으며 특히 편도는 후각신경세포와 2개의 시냅스로 떨어져 있고, 해마는 후각신경세포와 3개의 시냅스로 떨어져 있는데 냄새와 관련된 정보는 특히 해마에서 조직화된다. 해마에서는 모든 사건이 기억으로 전환되는데 다시 떠올릴 때에 마치 영화를 보는 것이 펼쳐지는 기억으로 당사자의 견해가 들어간 특정 경험이 일화기억으로 저장된다.The Brodmann area, which is related to the olfactory cortex in the cerebral cortex, is 28 and 34 in the middle cotyledons, and the olfactory experience is stored in memories. Especially, the smell has the strongest relationship among the senses and the olfactory experience lasts for one to several decades do. The olfactory region is related to the area that controls the emotions in the limbic system. In particular, one part is separated from the two synapses with the olfactory nerve cells, and the hippocampus is separated from the three synapses with the olfactory neurons. The information related to the smell is especially organized in the hippocampus . In the hippocampus, all events are converted into memories. When they are recalled, memories of watching movies are stored as anecdotal memories.
후각 기억은 특정한 냄새를 맡거나 혹은 냄새를 함유하는 음식물을 섭취하고 나서 일어나는데 인간이 특정한 음식냄새를 기억하는 것은 살아온 지역과 그 지역의 음식문화와 밀접한 관련이 있는 것으로 알려져 있다(McClure SM, Li J, Tomlin D, Cypert KS, Montaque LM, Montaque RP (2004) Neural correlates of behavioral preference for culturally familiar drings. Neuron 44(2):379-387). 예를 들어 다양한 김치의 냄새를 기억하는 것은 그 김치의 향을 맡아 보았거나 김치를 씹어 먹어본 사람만이 기억할 수 있다. Olfactory memory is known to take place after taking a specific smell or eating a smell containing food, and it is known that human remembrance of a particular smell of food is closely related to the living area and its food culture (McClure SM, Li J , Tomlin D, Cypert KS, Montaque LM, and Montaque RP (2004) Neural correlates of behavioral preference for culturally familiar drings Neuron 44 (2): 379-387). For example, remembering the smell of various kinds of kimchi can be remembered only by those who have smelled the kimchi or have chewed it.
매실은 약알카리성 식품으로 구연산, 무기질 등 유익한 영양소를 다량으로 함유하고 있어 인체의 혈액을 약알카리성으로 만들고 정혈작용, 강장작용, 보간작용, 피로회복, 노화방지, 살균작용 등을 하는 것으로 알려져 있다. 매실과육의 성분은 매실과육 100 g당 수분 90.1 g, 단백질 0.7 g, 지질 0.5 g, 당질 7.6 g, 섬유질 0.6 g, 회분 0.5 mg, 칼슘 12 mg, 인 14 mg, 철 0.6 mg, 나트륨 2 mg, 유기산 90.4 mg으로 구성되어 있다. 매실에 함유된 유기산의 조성은 품종별로 차이가 있으나 전체적으로 성숙이 진행됨에 따라 사과산은 56~70%에서 13~19%로 감소하며, 구연산은 23~36%에서 76~82%로 함량이 증가하며, 이 외에도 미량의 주석산, 호박산, 카테킨산이 함유되어 있다.Plum is a weak alkaline food containing a large amount of beneficial nutrients such as citric acid and minerals, making the blood of the body slightly alkaline, and it is known that it acts on the blood of the body, such as blood circulation, tonic action, interpolation action, fatigue recovery, aging prevention and sterilization. The content of plum pulp is 90.1 g of water per 100 g of plum pulp, 0.7 g of protein, 0.5 g of lipid, 7.6 g of saccharides, 0.6 g of fiber, 0.5 mg of ash, calcium of 12 mg, phosphorus of 14 mg, iron of 0.6 mg, And 90.4 mg of organic acid. The composition of organic acid contained in plum varies depending on the cultivars. However, the content of malic acid decreases from 56 ~ 70% to 13 ~ 19% and the content of citric acid increases from 23 ~ 36% to 76 ~ 82% , And a small amount of tartaric acid, succinic acid, and catechinic acid.
매실에 다량 함유되어 있는 구연산은 우리 몸의 피로 물질인 젖산을 분해시켜 몸 밖으로 배출시키는 작용을 하는 것으로 알려져 있다. 또한, 매실에는 간의 기능을 상승시키는 물질로 알려진 피루브산 성분이 함유되어 있으며, 인체에 축적되는 독성물질을 분해하는 피크린산 성분이 미량 함유되어 있어 식중독, 배탈 등 음식으로 인한 질병을 예방 치료하는데 효과적인 식품으로 이미 널리 알려져 있으며, 최근 항암식품으로서의 매실의 기능이 부각되어 이에 관한 연구가 활발하게 진행되고 있다. 또한 매실에는 강한 해독작용과 살균효과가 있는 카테킨산이 함유되어 있어 장내의 살균성을 높여 장의 염증과 이상 발효를 막는다고 알려져 있다.It is known that citric acid, which is contained in a large amount in the plum, acts to dissolve lactic acid, which is the fatigue substance of our body, and to discharge it out of the body. In addition, the plum contains pyruvic acid component, which is known as a substance that elevates liver function. It contains a small amount of picric acid component that decomposes toxic substances accumulated in the human body, and is effective in preventing and treating diseases caused by food poisoning, Recently, the function of plums as anticancer foods has been highlighted and researches on them have been actively carried out. It is also known that plum contains catechin acid, which has strong detoxifying action and sterilizing effect, to increase intestinal bactericidal action to prevent inflammation and abnormal fermentation of the intestines.
한국등록특허 제0799293호에는 피부염 치료 및 예방용 매실 추출 조성물이 개시되어 있으며, 한국등록특허 제1216183호에는 매실을 이용한 건강식품 조성물이 개시되어 있으나, 본 발명의 집중력 강화 및 심리적 안정용 매실차 조성물과는 상이하다.
Korean Patent No. 0799293 discloses a composition for extracting and extracting plums for treatment and prevention of dermatitis and Korean Patent No. 1216183 discloses a composition for health food using plum, .
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명자들은 매실차 조성물을 이용하여 뇌파 변화를 분석한 결과, 본 발명의 매실차 조성물은 우측 전전두엽에서 AA(Absolute Alpha Power Spectrum) 및 ASA(Absolute Slow Alpha Power Spectrum)의 증가를, 좌측 전두엽에서 RLB(Relative Low Beta Power Spectrum) 및 RST(Ratio of SMR to Theta)의 감소를, 우측 전두엽 및 좌측 측두엽에서 ASEF(Spectral edge frequency 50% of alpha spectrum band)의 감소를 유도하는 것을 확인함으로써, 본 발명을 완성하였다.
As a result of analyzing EEG changes using the mucilage tea composition, the present inventors have found that the mucilage composition of the present invention has an AA (Absolute Alpha Power Spectrum) and an ASA (RLB) and Ratio (Ratio of SMR to Theta) in the left frontal lobe and ASEF (Spectral edge frequency 50% of the alpha spectrum band) in the right frontal lobe and left temporal lobe ), Thereby completing the present invention.
상기 과제를 해결하기 위해, 본 발명은 매실 당절임, 액상과당 및 구연산을 혼합한 후 농축한 농축물을 유효성분으로 함유하는 집중력 강화 및 심리적 안정용 매실차 조성물을 제공한다.In order to solve the above problems, the present invention provides a concentrate-strengthening and psychological stabilizing plum tea composition containing, as an active ingredient, a concentrate obtained by mixing pickled plum, liquid fructose and citric acid and then concentrating the concentrate.
또한, 본 발명은 상기 매실차 조성물을 포함하는 집중력 강화 및 심리적 안정용 건강기능식품을 제공한다.Further, the present invention provides a health functional food for enhancing concentration and psychological stability comprising the above-mentioned mucilage tea composition.
또한, 본 발명은 (a) 매실과 설탕을 혼합하여 매실 당절임을 준비하는 단계; (b) 상기 (a)단계의 준비한 매실 당절임, 액상과당 및 구연산을 혼합하여 혼합물을 준비하는 단계; 및 (c) 상기 (b)단계의 준비한 혼합물을 농축하는 단계를 포함하는 집중력 강화 및 심리적 안정 효과를 지니는 매실차의 제조방법을 제공한다.The present invention also relates to a method for preparing a sweet potato comprising the steps of: (a) mixing plums and sugar to prepare pickles per plum; (b) preparing a mixture by mixing pickles, liquid fructose and citric acid prepared in step (a); And (c) concentrating the mixture prepared in step (b). The present invention also provides a method for producing a plum tea having a concentration-strengthening effect and a psychological stabilizing effect.
또한, 본 발명은 상기 방법으로 제조된 집중력 강화 및 심리적 안정 효과를 지니는 매실차를 제공한다.
Further, the present invention provides a plum tea having the concentration-strengthening and psycho-stabilizing effect produced by the above method.
본 발명의 매실차 조성물은 매실차 섭취를 통해, 우측 전전두엽에서 AA 및 ASA의 증가를 유도하고, 좌측 전두엽에서 RLB 및 RST의 감소를 유도하며, 우측 전두엽 및 좌측 측두엽에서 ASEF의 감소를 유도하여 집중력 강화 및 심리적 안정 효과를 얻을 수 있다. 또한, 본 발명의 매실차 조성물을 식품에 첨가하여 집중력 강화 및 심리적 안정 효과를 유도하는 건강기능식품의 개발에 사용될 수 있다.
The mucilage composition of the present invention induces an increase in AA and ASA in the right prefrontal cortex, induces a decrease in RLB and RST in the left frontal lobe, and a decrease in ASEF in the right frontal lobe and left temporal lobe, Strengthening and psychological stabilization effect can be obtained. In addition, the present invention can be used for the development of a health functional food which enhances concentration and induces a psychological stabilizing effect by adding the mucilage tea composition of the present invention to food.
도 1은 뇌파 측정을 위해 인간의 두뇌에 전극을 붙이는 부위를 제시한 10-20 국제표준 전극부착법을 보여주는 사진이다.
도 2는 피험자의 두뇌에 EGG용 모자를 씌우고 뇌파를 측정하는 모습을 보여주는 사진이다.
도 3은 물 시음(좌측)과 매실차 시음(우측) 후 AA(Absolute Alpha Power Spectrum) 변화를 보여주는 뇌지도 맵핑 결과이다.
도 4는 물 시음(좌측)과 매실차 시음(우측) 후 ASA(Absolute Slow Alpha Power Spectrum) 변화를 보여주는 뇌지도 맵핑 결과이다.
도 5는 물 시음(좌측)과 매실차 시음(우측) 후 RLB(Relative Low Beta Power Spectrum) 변화를 보여주는 뇌지도 맵핑 결과이다.
도 6은 물 시음(좌측)과 매실차 시음(우측) 후 RST(Ratio of SMR to Theta) 변화를 보여주는 뇌지도 맵핑 결과이다.
도 7은 물 시음(좌측)과 매실차 시음(우측) 후 ASEF(Spectral edge frequency 50% of alpha spectrum band) 변화를 보여주는 뇌지도 맵핑 결과이다.FIG. 1 is a photograph showing a 10-20 international standard electrode attaching method showing a region where an electrode is attached to a human brain for EEG measurement.
FIG. 2 is a photograph showing an EGG cap placed on a subject's brain and measuring brain waves.
FIG. 3 shows a brain map mapping result showing an AA (Absolute Alpha Power Spectrum) change after a water tasting (left) and a plum tea tasting (right).
FIG. 4 shows a brain map mapping result showing the ASA (Absolute Slow Alpha Power Spectrum) change after the water tasting (left) and the plum tea tasting (right).
FIG. 5 shows a brain map mapping result showing the change of RLB (Relative Low Beta Power Spectrum) after a water tasting (left) and a plum tea tasting (right).
Fig. 6 shows the brain map mapping result showing the change of RST (Ratio of SMR to theta) after the water tasting (left) and the plum tea tasting (right).
FIG. 7 shows the brain map mapping results showing the ASEF (spectral edge frequency 50% of the alpha spectrum band) change after the water tasting (left) and the plum tea tasting (right).
본 발명의 목적을 달성하기 위하여, 본 발명은 매실 당절임, 액상과당 및 구연산을 혼합한 후 농축한 농축물을 유효성분으로 함유하는 집중력 강화 및 심리적 안정용 매실차 조성물을 제공한다.In order to accomplish the object of the present invention, the present invention provides a concentrate-enhancing and psychological stabilizing plum tea composition containing concentrate, which is obtained by mixing seaweed, liquid fructose and citric acid and concentrating the plum, as an active ingredient.
본 발명의 매실차 조성물에서, 상기 농축물은 구체적으로는 매실과 설탕을 0.8~1.2:0.8~1.2 중량비로 혼합한 매실 당절임 35~55 중량%, 액상과당 44.4~64.4 중량% 및 구연산 0.5~0.7 중량%를 혼합한 후 76~80 Brix가 될 때까지 농축한 농축물일 수 있으며, 더욱 구체적으로는 매실과 설탕을 1:1 중량비로 혼합한 매실 당절임 45 중량%, 액상과당 54.4 중량% 및 구연산 0.6 중량%를 혼합한 후 78 Brix가 될 때까지 농축한 농축물일 수 있다.In the mucilage tea composition of the present invention, the concentrate specifically contains 35 to 55% by weight of pickled plum, 44.4 to 64.4% by weight of liquid fructose, and 0.5 to 40% by weight of citric acid, which are mixed with 0.8 to 1.2: 0.7% by weight and then concentrated to 76-80 Brix. More specifically, 45% by weight of pickles and 54.4% by weight of liquid fructose mixed with 1: 1 weight ratio of plum and sugar, And 0.6% by weight of citric acid, and then concentrated to 78 Brix.
본 발명의 매실차 조성물은 우측 전전두엽에서 AA(Absolute Alpha Power Spectrum) 및 ASA(Absolute Slow Alpha Power Spectrum)의 증가를 유도하고, 좌측 전두엽에서 RLB(Relative Low Beta Power Spectrum) 및 RST(Ratio of SMR to Theta)의 감소를 유도하며, 우측 전두엽 및 좌측 측두엽에서 ASEF(Spectral edge frequency 50% of alpha spectrum band)의 감소를 유도하여 집중력 강화 및 심리적 안정 효과를 나타내는 것을 특징으로 한다.The meciller composition of the present invention induces an increase of AA (Absolute Alpha Power Spectrum) and ASA (Absolute Slow Alpha Power Spectrum) in the right prefrontal lobe, and the RLB (Relative Low Beta Power Spectrum) and the Ratio of SMR to RST Theta) and induces a decrease in ASEF (50% of the alpha spectrum band) in the right frontal and left temporal lobes, thereby enhancing concentration and enhancing psychological stability.
AA는 alpha파의 절대 파워를 뜻하는 것으로, 이완 및 안정감을 느낄 수 있는 상태가 된다. ASA는 slow alpha파의 절대 파워를 뜻하는 것으로, 이완을 느끼면서 집중할 수 있는 상태가 된다. 또한, RLB는 전체에서 low beta파의 비율을 의미하는 것이고, beta파는 일반적인 작업을 하거나 의식적인 행동을 할 때 나타나며 정신활동이 있을 때 활성화되므로, beta파의 감소는 두뇌 상태를 안정화시키고 이완시켜 심리적으로 편안함을 증가시킨다. RST는 전체 중 SMR파/theta파의 비율을 뜻하는 것으로, RST의 감소는 주변상황을 경계하는 주의능력이 감소한 것을 의미한다. 또한, ASEF의 감소는 뇌파 전체에서 빠른 알파파(fast alpha wave)의 비율이 감소하는 것을 의미하며, 안정 및 이완도가 증가한 것을 의미한다.AA stands for the absolute power of the alpha wave and is in a state of relaxation and sense of stability. ASA refers to the absolute power of the slow alpha wave, which allows you to concentrate while feeling relaxed. In addition, RLB refers to the ratio of low beta waves in the whole, and beta waves appear when doing general work or conscious actions and are activated when there is mental activity. Therefore, reduction of beta waves stabilizes and relaxes the brain state, To increase comfort. The RST means the ratio of the SMR wave / theta wave in the whole, and the decrease in RST means that the ability of attention to surroundings is decreased. In addition, the decrease in ASEF means that the proportion of fast alpha waves in the entire EEG decreases, indicating an increase in stability and relaxation.
또한, 본 발명은 상기 매실차 조성물을 포함하는 집중력 강화 및 심리적 안정용 건강기능식품을 제공한다.Further, the present invention provides a health functional food for enhancing concentration and psychological stability comprising the above-mentioned mucilage tea composition.
상기 건강기능식품은 여러 가지 영양제, 비타민, 광물(전해질), 합성 및 천연 풍미제, 착색제 및 증진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 천연 과일 주스 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. The health functional food may contain various nutrients, vitamins, minerals (electrolytes), synthetic and natural flavors, colorants and enhancers (cheese, chocolate etc.), pectic acid and its salts, alginic acid and its salts, pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonating agents used in carbonated drinks, and the like. It may also contain flesh for the production of natural fruit juices and vegetable drinks. These components may be used independently or in combination.
본 발명의 건강기능식품은 여러가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상기 천연 탄수화물은 포도당, 과당과 같은 모노사카라이드, 말토스, 슈크로스와 같은 디사카라이드, 및 덱스트린, 사이클로덱스트린과 같은 폴리사카라이드, 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 감미제로서는 타우마틴, 스테비아 추출물과 같은 천연 감미제나, 사카린, 아스파르탐과 같은 합성 감미제 등을 사용할 수 있다.The health functional food of the present invention may contain various flavors or natural carbohydrates as an additional ingredient. The natural carbohydrates are sugar saccharides such as monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, polysaccharides such as dextrin and cyclodextrin, xylitol, sorbitol and erythritol. Examples of sweeteners include natural sweeteners such as tau martin and stevia extract, synthetic sweeteners such as saccharin and aspartame, and the like.
본 발명은 또한,The present invention also relates to
(a) 매실과 설탕을 0.8~1.2:0.8~1.2 중량비로 혼합하여 매실 당절임을 준비하는 단계;(a) mixing plum and sugar at a weight ratio of 0.8-1.2: 0.8-1.2 to prepare pickles per plum;
(b) 혼합물 총 중량 기준으로, 상기 (a)단계의 준비한 매실 당절임 35~55 중량%, 액상과당 44.4~64.4 중량% 및 구연산 0.5~0.7 중량%를 혼합하여 혼합물을 준비하는 단계; 및(b) preparing a mixture by mixing 35 to 55 wt% of pickles, 44.4 to 64.4 wt% of liquid fructose, and 0.5 to 0.7 wt% of citric acid in the plum prepared in the step (a), based on the total weight of the mixture. And
(c) 상기 (b)단계의 준비한 혼합물을 76~80 Brix가 될 때까지 농축하는 단계를 포함하는 집중력 강화 및 심리적 안정 효과를 지니는 매실차의 제조방법을 제공한다.(c) concentrating the mixture prepared in step (b) until the mixture has a Brix of 76 to 80 Brix.
본 발명의 집중력 강화 및 심리적 안정 효과를 지니는 매실차의 제조방법은, 보다 구체적으로는The method for manufacturing a plum tea having the concentration strengthening effect and the psychological stabilizing effect of the present invention, more specifically,
(a) 매실과 설탕을 1:1 중량비로 혼합하여 매실 당절임을 준비하는 단계;(a) mixing plums and sugar at a weight ratio of 1: 1 to prepare pickles per plum;
(b) 혼합물 총 중량 기준으로, 상기 (a)단계의 준비한 매실 당절임 45 중량%, 액상과당 54.4 중량% 및 구연산 0.6 중량%를 혼합하여 혼합물을 준비하는 단계; 및(b) preparing a mixture by mixing 45 wt% of pickles, 54.4 wt% of liquid fructose, and 0.6 wt% of citric acid in the plum prepared in the step (a), based on the total weight of the mixture. And
(c) 상기 (b)단계의 준비한 혼합물을 78 Brix가 될 때까지 농축하는 단계를 포함할 수 있다.(c) concentrating the mixture prepared in step (b) until it reaches 78 Brix.
본 발명은 또한, 상기 방법으로 제조된 집중력 강화 및 심리적 안정 효과를 지니는 매실차를 제공한다.
The present invention also provides a plum tea having the concentration-enhancing and psychological stabilizing effect produced by the above-mentioned method.
이하, 본 발명을 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.
Hereinafter, the present invention will be described in detail with reference to examples. However, the following examples are illustrative of the present invention, and the present invention is not limited to the following examples.
제조예Manufacturing example 1. 매실차 1. Plum tea
(a) 씨와 꼭지를 제거한 매실을 습식분쇄기를 이용하여 분쇄한 매실과 설탕을 1:1 중량비율로 혼합하여 매실 당절임을 준비하였다.(a) The plum removed from the seeds and the nipple was pulverized with a wet grinder, and the plum and sugar were mixed in a weight ratio of 1: 1, and the pickled plums were prepared.
(b) 혼합물 총 중량 기준으로, 상기 (a)단계의 준비한 매실 당절임 45 중량%, 액상과당 54.4 중량% 및 구연산 0.6 중량%를 혼합하여 혼합물을 준비하였다.(b) 45% by weight of pickles, 54.4% by weight of liquid fructose and 0.6% by weight of citric acid in the prepared plums prepared in step (a) were mixed to prepare a mixture.
(c) 상기 (b)단계의 준비한 혼합물을 농축기를 이용하여 진공상태(진공기압 60 cmHg 기압 이상)에서 55±1℃로 당도 78±1 Brix가 될 때까지 농축하였다.
(c) The mixture prepared in the step (b) was concentrated to 55 ± 1 ° C in a vacuum state (vacuum air pressure of 60 cmHg or higher) using a concentrator until the sugar content reached 78 ± 1 Brix.
실시예Example 1. 매실차가 뇌파에 미치는 영향 분석 1. Analysis of Effect of Plum Tea on EEG
매실차의 시음이 인간의 뇌 활동에 어떠한 영향을 주었는지를 알고자 뇌파를 측정하였다. 뇌파 측정은 최대한 잡음이 혼입되지 않은 온도 23℃, 습도 50%가 유지되는 32.4 m2 크기의 실험실에서 남, 녀 각각 10명 총 20명의 피험자를 대상으로 수행하였다. 뇌파측정을 위해 사용한 뇌파측정기는 QEEG-64FX 시스템(LXE3208, LAXTHA Inc. 한국)이었으며, 피험자의 뇌파신호 측정은 LAXTHA사의 데이터 수집 장비 및 분석 프로그램(Telescan)을 이용하였다. 피험자들에게 10~20 국제표준전극 부착법을 이용하여 좌측과 우측 전전두엽(Fp1, Fp2, Fpz, Af3, Af4, Afz), 좌측과 우측 전두엽(F3, F4, F7, F8, Fz, Fc1, Fc2, Fc5, Fc6), 좌측과 우측 측두엽(T3, T4, T7, T8, Cp5, Cp6), 좌측과 우측 두정엽(P3, P4, P7, P8, Cp1, Cp2, Cz, Pz), 좌측과 우측 후두엽(O1, O2, Oz) 부분에 부착하고 오른쪽과 왼쪽 귓불에도 각각 그라운드 및 레퍼런스 전극을 부착하였다(도 1 및 2). 피험자가 눈을 감은 상태에서 맹물 시음(무자극)과 매실차 시음(유자극)으로 하여 각각 45초씩 측정하였다.We measured the EEG by knowing how the tasting of the plum tea affected human brain activity. EEG measurements were performed on a total of 20 subjects, 10 of each male and female, in a laboratory of 32.4 m 2 in which the noise was not mixed and the temperature was maintained at 23 ° C and 50% humidity. The brain waves were measured with the QEEG-64FX system (LXE3208, LAXTHA Inc. Korea). The EEG data of the subjects were measured using LAXTHA's data collection equipment and analysis program (Telescan). The left and right prefrontal cords (Fp1, Fp2, Fpz, Af3, Af4, Afz), left and right frontal lobes (F3, F4, F7, F8, Fz, Fc1, Fc2, Left and right temporal lobes (P3, P4, P7, P8, Cp1, Cp2, Cz, Pz), left and right temporal lobes (T3, T4, T7, T8, Cp5, Cp6) O1, O2, and Oz), and ground and reference electrodes were attached to the right and left earlobes, respectively (FIGS. 1 and 2). Subjects were measured for 45 seconds with eyes closed (no irritation) and with plum tea (with irritation).
매실차에 대한 뇌파측정을 통해 얻어진 데이터 처리는 피험자의 뇌파신호 중 대표적인 30초간의 뇌파신호만을 추출하여 뇌파일괄처리 프로그램(batch processing)으로 수행한 후, 통계분석 소프트웨어 프로그램인 SPSS(SPSS 23.0 version)를 이용하여 대응표본 T 검정을 수행하였다.Data processing through the EEG measurement of the plum tea was performed by extracting only the representative 30-second EEG signals among the subjects' EEG signals and performing batch processing of the brain waves. Then, SPSS (SPSS 23.0 version) To perform a corresponding sample T test.
매실차에 대한 데이터 분석을 위한 뇌파 지표의 종류는 표 1에, 그리고 각각의 뇌파 지표의 의미는 표 2에 나타내었다.
Table 1 shows the types of EEG indicators for analyzing data on plums, and Table 2 shows the meanings of EEG indices.
본 실시예에서 매실차에 대한 뇌파측정 결과, 25개의 뇌파분석 지표 중 AA(Absolute Alpha Power Spectrum), ASA(Absolute Slow Alpha Power Spectrum), RLB(Relative Low Beta Power Spectrum), RST(Ratio of SMR to Theta), ASEF(Spectral Edge Frequency 50% of Alpha Spectrum Band) 지표에서만 통계학적인 유의성이 있는 것으로 나타났다(p<0.05). 나머지 20개의 파워스펙트럼은 차이가 발견되지 않았기 때문에 본 실시예에서는 기술하지 않았다.
As a result of the EEG measurement for the plum blossom according to the present embodiment, Absolute Alpha Power Spectrum (ASA), Relative Low Beta Power Spectrum (RLB), Ratio of SMR to RST Theta) and ASEF (Spectral Edge Frequency 50% of Alpha Spectrum Band) were statistically significant ( p <0.05). The remaining 20 power spectra were not described in this embodiment because no difference was found.
1. AA(Absolute Alpha Power Spectrum) 지표1. Absolute Alpha Power Spectrum (AA)
AA 지표는 8 Hz 이상 14 Hz 미만의 주파수 영역의 뇌파로 두뇌의 안정 상태를 나타내며, AA 지표의 증가 시 창조적 사고와 아이디어가 발생한다고 보고된 바 있다. 매실차의 시음으로 뇌파분석 지표인 AA 평균값이 통계적으로 유의미하게 증가하였다(p<0.05).The AA index indicates the stable state of the brain in the EEG frequency range from 8 Hz to less than 14 Hz. It has been reported that when the AA index increases, creative thinking and ideas occur. The AA mean value of EEG analysis was statistically significant ( p <0.05).
2. ASA(Absolute Slow Alpha Power Spectrum) 지표2. Absolute Slow Alpha Power Spectrum (ASA) Indicator
ASA 지표는 slow alpha(8~10 Hz)파로서 휴식을 취하고 있을 때나 약간 졸릴 때 나타나며 휴식을 하면서도 언제든지 활동할 수 있게 집중하고 있는 상태일 때 확인된다. 매실차의 시음으로 뇌파분석 지표인 RLB 평균값이 통계적으로 유의미하게 증가하였다(p<0.05).The ASA indicator is a slow alpha (8 to 10 Hz) wave that appears when you are at rest or when you are a bit sleepy, and you are at rest and concentrating on activity at any time. The mean value of RLB, which is an indicator of EEG analysis, increased statistically significantly ( p <0.05).
3. RLB(Relative Low Beta Power Spectrum) 지표3. RLB (Relative Low Beta Power Spectrum) Indicator
RLB 지표는 뇌파 스펙트럼에서 전체 주파수 영역의 절대 파워에 대한 low beta 대역의 절대파워 비로서 low beta파 영역(12~15 Hz)을 전체 주파수 영역(4~50 Hz)으로 나누어 준 스펙트럼 값을 의미한다. 매실차의 시음으로 뇌파분석 지표인 RLB 평균값이 통계적으로 유의미하게 감소하였다(p<0.05).The RLB index is the absolute power ratio of the low beta band to the absolute power of the entire frequency domain in the EEG spectrum, which is the spectrum value obtained by dividing the low beta wave region (12 to 15 Hz) by the entire frequency region (4 to 50 Hz) . The mean value of RLB, which is an indicator of EEG analysis, decreased statistically significantly ( p <0.05).
4. RST(Ratio of SMR to Theta) 지표4. Ratio of SMR to theta (RST)
RST 지표는 뇌파 스펙트럼에서 SMR/theta 비로 SMR파 영역(12~15Hz)을 theta파 영역(4~8Hz)으로 나누어준 스펙트럼 값을 의미하며, 주변상황을 경계하는 주의능력을 나타내는 뇌파분석 지표로 사용된다. 매실차의 시음으로 뇌파분석 지표인 RST 평균값이 통계적으로 유의미하게 감소하였다(p<0.05).The RST index refers to the spectral value obtained by dividing the SMR wave field (12 to 15 Hz) by the theta wave field (4 to 8 Hz) with the SMR / theta ratio in the EEG spectrum and is used as an EEG analysis index do. The mean value of RST as an indicator of EEG decreased statistically significantly (p <0.05).
5. ASEF(Spectral Edge Frequency 50% of Alpha Spectrum Band) 지표5. ASEF (Spectral Edge Frequency 50% of Alpha Spectrum Band)
ASEF 지표는 alpha파의 SEF50으로 쾌적성을 나타내는 뇌파지표로 알파파의 뇌파 활성도를 확인이 가능하다고 알려져 있다. 매실차의 시음으로 뇌파분석 지표인 ASEF 평균값이 통계적으로 유의미하게 감소하였다(p<0.05).The ASEF index is an alpha wave of SEF50, which is known to be a comfortable EEG index. The mean value of ASEF, which is an indicator of EEG analysis, decreased statistically by tasting the plum tea ( p <0.05).
상기의 결과들을 토대로, 본 발명의 매실차의 시음을 통해 뇌파의 변화를 유도하여 집중력 강화와 심리적 안정을 유도하여 편안함을 이끌어주는 효과를 나타낼 수 있음을 알 수 있었다.
Based on the above results, it was found that the tasting of the plum tea of the present invention induces the change of the brain waves, thereby enhancing the concentration and inducing the psychological stability.
Claims (7)
35 to 55% by weight of pickled plum, 44.4 to 64.4% by weight of liquid fructose and 0.5 to 0.7% by weight of citric acid, mixed with plum and sugar at a ratio of 0.8 to 1.2: 0.8 to 1.2, (RLB) and Ratio (RST) in the left frontal lobe. In the left frontal lobe, RLB (Relative Low Beta Power Spectrum) and RST SMR to theta) and decreasing ASEF (50% of the alpha spectrum band) in the right frontal and left temporal lobes.
A health functional food for enhancing concentration and psychological stability comprising the plum tea composition according to claim 1.
The composition according to claim 4, further comprising at least one compound selected from the group consisting of vitamins, minerals, flavors, colorants, pectic acid and salts thereof, alginic acid and salts thereof, organic acids, protective colloid thickening agents, pH adjusting agents, stabilizers, preservatives, glycerin, And a carbonating agent used in a carbonated beverage. ≪ Desc / Clms Page number 24 >
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170108816A KR101844369B1 (en) | 2017-08-28 | 2017-08-28 | Plum tea composition for enhancing concentration and psychological stability and uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170108816A KR101844369B1 (en) | 2017-08-28 | 2017-08-28 | Plum tea composition for enhancing concentration and psychological stability and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101844369B1 true KR101844369B1 (en) | 2018-04-02 |
Family
ID=61976123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170108816A KR101844369B1 (en) | 2017-08-28 | 2017-08-28 | Plum tea composition for enhancing concentration and psychological stability and uses thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101844369B1 (en) |
-
2017
- 2017-08-28 KR KR1020170108816A patent/KR101844369B1/en active IP Right Grant
Non-Patent Citations (1)
Title |
---|
"170127 제주이야기 차 선물세트 : 한라 3색 선물세트 / 제주특산 꼬마 6종 선물세트", 네이버 블로그, http://blog.naver.com/jhjwell/220829648757(2017. 1. 31.)* |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8206764B2 (en) | Black soybean hull extract, method for obtaining, and use thereof | |
US11564952B2 (en) | Water-soluble and water-insoluble propolis products with high antioxidant capacity and their production methods | |
KR101897595B1 (en) | High concentration berry beverage with anti-oxidative activity and manufacturing method thereby | |
JP2020530262A (en) | Beet juice with enhanced intestinal absorption rate and its manufacturing method and applications | |
KR20170078975A (en) | Bread and bread composition with antioxidative activity containing the rind of apples and blueberries | |
DE4320526C2 (en) | Oil preparation and method of making the same | |
KR101844369B1 (en) | Plum tea composition for enhancing concentration and psychological stability and uses thereof | |
KR101922466B1 (en) | Method for producing Hydrangea macrophylla tea having attention and concentration strengthening effect | |
KR101847375B1 (en) | Dandelion mixed extract composition for improving brain comfort when tasting and uses thereof | |
KR101855740B1 (en) | Mixed composition of vitamin and mineral for awakening and enhancing concentration and uses thereof | |
KR101997023B1 (en) | Hydrangea macrophylla extract mixed composition for relaxation and reducing concentration and uses thereof | |
KR101333152B1 (en) | Honey containing lavender | |
CN101700117B (en) | Preparation method of tea tablet for releasing eyestrain | |
KR20110036329A (en) | Food composition for improving concentration and alleviating stress containing theanine and extract of oat | |
CN106551385A (en) | A kind of functional composition with increase bone density and its application | |
CN109673802A (en) | A kind of phosphatidylserine fructus alpiniae oxyphyllae pressed candy and preparation method and application | |
KR101855741B1 (en) | Mixed composition of β-carotene for relaxation and uses thereof | |
KR20180072569A (en) | Amino acid beverage comprising allulose | |
KR101980599B1 (en) | Mixed fermentation solution composition of Orostachys japonica and pine needle for enhancing attention and concentration and uses thereof | |
KR100895969B1 (en) | Development of concentrated onion extract having antioxidant and anticholesterol activities | |
KR101877290B1 (en) | Aroma composition with grape flavor containing essential oil of Schisandra chinensis and Angelica gigas for enhancing concentration state and uses thereof | |
KR20190024859A (en) | Schisandra chinensis tea composition for awakening and enhancing concentration and uses thereof | |
KR20190024858A (en) | Hallabong tea composition for relaxation and uses thereof | |
KR100547007B1 (en) | Method for production of solvent for high solution of calcium, calcium powder with high solubility thereof and calcium liquid thereof | |
KR20190052958A (en) | Aronia fermentation solution composition for relaxation and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
R401 | Registration of restoration |